Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligonucleotides for treating expanded repeat diseases

Oligonucleotides for treating expanded repeat diseases

US Patent 11674139 · Granted Jun 13, 2023

Estimated economic value: $90,428,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic peptide oligonucleotide conjugates2025
Exon skipping oligomer conjugates for muscular dystrophy2025
Chimeric peptides for antisense delivery2025
Peptide oligonucleotide conjugates2025
Trimeric peptides for antisense delivery2024
Cell-penetrating peptides for antisense delivery2024
Modified antisense oligomers for exon inclusion in spinal muscular atrophy2024
Methods and compositions for preventing type 1 diabetes2024
Peptide oligonucleotide conjugates2023
Peptide oligonucleotide conjugates2023
Exon skipping oligomer conjugates for muscular dystrophy2023
Exon skipping oligomer conjugates for muscular dystrophy2022